AlphaCrest Capital Management’s Guardant Health GH Stock Holding History

AlphaCrest Capital Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-7,732	Closed	-$416K	–	459
2022 Q3	$416K	Buy	+7,732	New	+$397K	0.03%	1041
2021 Q4	–	Sell	-2,336	Closed	-$292K	–	1392
2021 Q3	$292K	Sell	2,336 -5,004	-68%	-$595K	0.02%	1114
2021 Q2	$912K	Buy	7,340 +4,240	+137%	+$570K	0.04%	707
2021 Q1	$473K	Sell	3,100 -2,100	-40%	-$317K	0.03%	822
2020 Q4	$670K	Buy	5,200 +2,900	+126%	+$334K	0.06%	490
2020 Q3	$257K	Sell	2,300 -2,100	-48%	-$192K	0.03%	944
2020 Q2	$357K	Buy	+4,400	New	+$355K	0.06%	545

Other funds holding GH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

AlphaCrest Capital Management's GH Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Guardant Health (GH) in Q4 2022, closing a stake of 7,732 shares — an estimated $416K sold.

AlphaCrest Capital Management first reported a position in GH in Q2 2020 and held it in 7 quarters. The position peaked at $912K in Q2 2021. 292 funds tracked by Wall St. Rank hold GH as of Q4 2022.

AlphaCrest Capital Management reported no remaining Guardant Health position as of Q4 2022 after selling out during the quarter.
AlphaCrest Capital Management sold 7,732 Guardant Health shares in Q4 2022, an estimated $416K.
AlphaCrest Capital Management first reported a position in Guardant Health in Q2 2020 and held it in 7 quarters.
AlphaCrest Capital Management's Guardant Health position peaked at $912K in Q2 2021.
292 funds tracked by Wall St. Rank held Guardant Health as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.